Diabetic Dyslipidemia

Diabetic Dyslipidemia

You have access
Effect of Loss-of-Function Genetic Variants in PCSK9 on Glycemic Traits, Neurocognitive Impairment, and Hepatobiliary Function
Jonas Ghouse, Gustav Ahlberg, Henning Bundgaard, Morten S. Olesen

Diabetes Care Nov 2021, dc210955; DOI: 10.2337/dc21-0955
You have access
Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes
Farsad Afshinnia, Thekkelnaycke M. Rajendiran, Chenchen He, Jaeman Byun, Daniel Montemayor, Manjula Darshi, Jana Tumova, Jiwan Kim, Christine P. Limonte, Rachel G. Miller, Tina Costacou, Trevor J. Orchard, Tarunveer S. Ahluwalia, Peter Rossing, Janet K. Snell-Bergeon, Ian H. de Boer, Loki Natarajan, George Michailidis, Kumar Sharma, Subramaniam Pennathur

Diabetes Care Sep 2021, 44 (9) 2098-2106; DOI: 10.2337/dc21-0737
You have access
Carbamylated HDL and Mortality Outcomes in Type 2 Diabetes
David T.W. Lui, Ching-Lung Cheung, Alan C.H. Lee, Ying Wong, Sammy W.M. Shiu, Kathryn C.B. Tan

Diabetes Care Mar 2021, 44 (3) 804-809; DOI: 10.2337/dc20-2186
Open Access
Depletion of Adipocyte Becn1 Leads to Lipodystrophy and Metabolic Dysregulation
Young Jin, Yul Ji, Yaechan Song, Sung Sik Choe, Yong Geun Jeon, Heeju Na, Tae Wook Nam, Hye Jeong Kim, Hahn Nahmgoong, Sung Min Kim, Jae-woo Kim, Ki Taek Nam, Je Kyung Seong, Daehee Hwang, Chan Bae Park, In Hye Lee, Jae Bum Kim, Han-Woong Lee

Diabetes Jan 2021, 70 (1) 182-195; DOI: 10.2337/db19-1239
You have access
High-Coverage Targeted Lipidomics Reveals Novel Serum Lipid Predictors and Lipid Pathway Dysregulation Antecedent to Type 2 Diabetes Onset in Normoglycemic Chinese Adults
Jieli Lu, Sin Man Lam, Qin Wan, Lixin Shi, Yanan Huo, Lulu Chen, Xulei Tang, Bowen Li, Xueyan Wu, Kui Peng, Mian Li, Shuangyuan Wang, Yu Xu, Min Xu, Yufang Bi, Guang Ning, Guanghou Shui, Weiqing Wang

Diabetes Care Nov 2019, 42 (11) 2117-2126; DOI: 10.2337/dc19-0100
You have access
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
Lawrence A. Leiter, Hwee Teoh, David Kallend, R. Scott Wright, Ulf Landmesser, Peter L.J. Wijngaard, John J.P. Kastelein, Kausik K. Ray

Diabetes Care Jan 2019, 42 (1) 173-176; DOI: 10.2337/dc18-1491
You have access
CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet
Lin Zhu, Thao Luu, Christopher H. Emfinger, Bryan A. Parks, Jeanne Shi, Elijah Trefts, Fenghua Zeng, Zsuzsanna Kuklenyik, Raymond C. Harris, David H. Wasserman, Sergio Fazio, John M. Stafford

Diabetes Dec 2018, 67 (12) 2494-2506; DOI: 10.2337/db18-0474
Open Access
Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes
Jing-Lu Jin, Ye-Xuan Cao, Hui-Wen Zhang, Di Sun, Qi Hua, Yan-Fang Li, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Ying Gao, Qiu-Ting Dong, Hui-Hui Liu, Qian Dong, Jian-Jun Li

Diabetes Care Jul 2019, 42 (7) 1312-1318; DOI: 10.2337/dc19-0274
You have access
Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
Anna V. Mathew, Lei Li, Jaeman Byun, Yanhong Guo, George Michailidis, Mamta Jaiswal, Y. Eugene Chen, Rodica Pop-Busui, Subramaniam Pennathur

Diabetes Care Nov 2018, 41 (11) 2431-2437; DOI: 10.2337/dc18-0049
Open Access
Response to Comment on de Carvalho et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364–367
Luiz Sérgio F. de Carvalho, Alessandra M. Campos, Andrei C. Sposito

Diabetes Care Apr 2018, 41 (4) e70-e71; DOI: 10.2337/dci17-0069

Main menu

User menu

Search

Diabetic Dyslipidemia

Pages

Navigate

More Information

Other ADA Resources